Baxter International (BAX) reported $3.89 billion in revenue for the quarter ended December 2023, representing a year-over-year decline of 0.1%. EPS of $0.88 for the same period compares to $0.88 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $3.8 billion, representing a surprise of +2.28%. The company delivered an EPS surprise of +2.33%, with the consensus EPS estimate being $0.86.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings - ...

Baxter International (BAX) came out with quarterly earnings of $0.88 per share, beating the Zacks Consensus Estimate of $0.86 per share. This compares to earnings of $0.88 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 2.33%. A quarter ago, it was expected that this drug and medical device maker would post earnings of $0.66 per share when it actually produced earnings of $0.68, delivering a surprise of 3.03%.Over the last fou ...

| --- | --- | |--------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------| | UNITED STATES SECURITIES AND EXCHANGE Washington, D.C. 20549 | COMMISSION | | FORM 10-K | _____________________________________________________________________________________________ | (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its fourth-quarter 2023 financial results on Thursday, February 8, 2024 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://conferencingportals.com/event/etCeELhb to pre-register for the call and receive the call information. This call is also being webcast and can be accessed through Baxter’s website at www.baxter.com. The con ...

T HI RD-Q UA RT ER 2023 EA RNI NGS Baxter International Inc. November 2, 2023 FORWA R D- LOOKING STAT EM ENT S This pr ...

Baxter International Inc. (NYSE:BAX) Q3 2023 Earnings Conference Call November 2, 2023 8:30 AM ET Company Participants Joe Almeida - Chairman, Chief Executive Officer Joel Grade - Executive Vice President, Chief Financial Officer Brian Stevens - Senior Vice President, Chief Accounting Officer, Controller, former Interim CFO Clare Trachtman - Senior Vice President, Chief Investor Relations Officer Conference Call Participants Matt Miksic - Barclays Vijay Kumar - Evercore ISI Rick Wise - Stifel Pito Chickerin ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________________________________________________________________ FORM 10-Q _________________________________________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to C ...

Baxter International Inc. (NYSE:BAX) Q2 2023 Earnings Conference Call July 27, 2023 8:30 AM ET Company Participants Clare Trachtman - Vice President of Investor Relations Jose Almeida - Chairman, President & Chief Executive Officer Brian Stevens - Interim Chief Financial Officer & Chief Accounting Officer Conference Call Participants Robert Marcus - JPMorgan Larry Biegelsen - Wells Fargo Danielle Antalffy - SVB Securities Patrick Wood - Morgan Stanley Travis Steed - Bank of America Securities Vijay Kumar - ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________________________________________________________________ FORM 10-Q _________________________________________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commis ...

FI RS T-Q UA RT ER 2023 EA RNI NGS Baxter International Inc. April 27, 2023 FORWA R D- LOOKING STAT EM ENT S This p ...